"Our Manifesto Where science and agility integrate and combine. Cutting through silos across a range of drug development capabilities. Saving precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast."

During the past decade, Quotient Sciences conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 5 clinical trials were completed, i.e. on average, 7.8% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 4 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Quotient Sciences" #1 sponsor was "Genentech, Inc." with 8 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "MODAG GmbH" with 3 trials sponsored and "Balance Therapeutics" with 3 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Quotient Sciences" #1 collaborator was "Quotient Sciences" with 12 trials as a collaborator, "Quotient Clinical" with 6 trials as a collaborator, "Aptuit" with 3 trials as a collaborator, "Banook Group" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Quotient Sciences" are "Healthy" (12 trials), "Healthy Volunteers" (12 trials), "Healthy Volunteer" (4 trials), "Cystic Fibrosis" (2 trials) and "Healthy Participants" (2 trials). Many other conditions were trialed in "Quotient Sciences" in a lesser frequency.

Most popular intervention types in "Quotient Sciences" are "Drug" (66 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Rabeprazole" (3 trials), "GDC-0853" (2 trials), "Midazolam" (2 trials) and "anle138b" (2 trials). Other intervention names were less common.

The vast majority of trials in "Quotient Sciences" are 33 trials for "All" genders, 30 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Quotient Sciences". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Quotient Sciences, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Quotient Sciences, 66 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".